Levocetirizina Eg

Levocetirizine, the active ingredient in Levocetirizina Eg, is a antihistamine presented as an oral tablet for oral use. It treats allergic rhinitis and chronic idiopathic urticaria in adults and children.

GNH USA supplies Levocetirizina Eg as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levocetirizine is an antihistamine that acts on the histamine H1‑receptor pathway to relieve allergic conditions.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and watery discharge. Chronic idiopathic urticaria: alleviates hives and associated itching. Seasonal allergic conjunctivitis: helps lessen eye itching and redness.

Levocetirizine is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Drowsiness or fatigue - Dry mouth - Headache - Taste alteration - Nausea - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Angioedema or severe swelling - Anaphylactic reactions - Stevens‑Johnson syndrome or other severe skin eruptions - Rapid heart rate (tachycardia) - Hepatic injury - Blood dyscrasias such as neutropenia

Use levocetirizine with caution and follow clinical guidance.

Renal function assessment: adjust dose in severe renal impairment. Hepatic impairment: monitor liver function before and during therapy. Sedation risk: avoid operating machinery if drowsiness occurs. Pediatric use: not recommended for children under six years of age without specialist advice. Concomitant CNS depressants: monitor for additive sedation. Store at below 25°C: keep in the original pack, protect from moisture.

Levocetirizine may interact with other substances; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Alcohol: can increase sedation and impair cognition. - Other antihistamines: additive drowsiness and anticholinergic effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise plasma concentrations.

Moderate Interactions (Monitor Closely): - Theophylline: levocetirizine may increase its plasma levels. - Ritonavir or other protease inhibitors: may modestly elevate levocetirizine exposure. - Certain antidepressants (e.g., fluoxetine): monitor for enhanced sedation.